Center For Scientific Review; Notice of Closed Meetings, 56591-56592 [2014-22456]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 183 / Monday, September 22, 2014 / Notices
Dr., Element Bldg., Rockville, MD
20857.
Dated: September 16, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–22460 Filed 9–19–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Direct Impact Corona
Ionization Mass Spectrometry
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This is notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the Food and Drug Administration,
an agency within the Department of
Health and Human Services, through
the National Institutes of Health Office
of Technology Transfer is contemplating
the grant of an exclusive worldwide
license to practice the inventions
embodied in HHS Ref. No. E–258–2011/
0, ‘‘Direct Impact Corona Ionization
(DICI) Mass Spectrometry;’’ U.S. Patent
8,704,169, to Vivione Biosciences, Inc.,
a corporation incorporated under the
laws of the State of Arkansas, having a
principle place of business at 515 W.
Matthews Ave., Jonesboro, AR 72401.
The United States of America is the
assignee of the patent rights pertaining
to this invention.
The exclusivity period of the
contemplated license may be granted for
no more than seven (7) years, may be
territorially limited to the United States
and may be limited to a field of use
directed to direct impact corona
ionization mass spectrometry pattern
recognition devices and systems for
detection of small molecules and
microbiological agents.
DATES: Only written comments and/or
applications for a license that are
received by the NIH Office of
Technology Transfer on or before
October 22, 2014 will be considered.
ADDRESSES: Requests for a copy of the
patent application, inquiries, comments
and other materials relating to the
contemplated license should be directed
to: Michael Shmilovich, Esq, CLP,
Senior Licensing and Patent Manager,
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville, MD
20852–3804; Telephone: (301) 435–
5019; Facsimile: (301) 402–0220; Email:
shmilovm@mail.nih.gov. A signed
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:07 Sep 19, 2014
Jkt 232001
confidential disclosure agreement may
be required to receive copies of the
patent application assuming it has not
already been published under the
publication rules of either the U.S.
Patent and Trademark Office or the
World Intellectual Property
Organization.
SUPPLEMENTARY INFORMATION: E–258–
2011/0 (U.S. Patent 8,704,169)—The
invention relates to the uses of an
AccuTOF DART (time-of-flight mass
spectrometer coupled to direct analysis
in real time) mass spectrometer for
qualitatively analyzing samples
(originally designed for microbes) based
on the serendipitous discovery that
glowing direct impact corona ionization
greatly enhances sensitivity of
identification. This direct impact corona
ionization occurred while repositioning
the stainless steel pin too close to the
grid of the ion source gun. Examination
revealed that not only did the peak
intensity increase by 490 fold but the
spectral information was well beyond
anything seen before with only the
normal ionization mode on the same
instrument. Initially, pyrolysis was
considered necessary for vaporizing low
volatility components of microbiological
analytes, a prerequisite for ionizing and
introducing samples into the mass
spectrometer. However, pyrolysis
introduced particles from burned
electrical wiring insulation because of
the high current necessary. As an
alternative, the inventors replaced the
pyrolysis device with a power generator
used for direct corona ionizing
microbiological analytes in a controlled
fashion. Furthermore, a small custommade glass cylinder with two
juxtaposing holes on each side was set
up within the sample introduction
chamber to exclude oxygen thus
preventing oxidation of microbiological
analytes. Additionally, the insulation
provided by this cylinder kept out
ambient moisture thus ensuring proton
transfer from water molecules would
not contribute to irreproducible
ionization of the analyte.
The prospective exclusive license will
be royalty-bearing and comply with the
terms and conditions of 35 U.S.C. 209
and 37 CFR part 404. The prospective
exclusive license may be granted unless,
within thirty (30) days from the date of
this published notice, the National
Institutes of Health Office of Technology
Transfer receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR part 404.
Properly filed competing applications
for a license filed in response to this
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
56591
notice will be treated as objections to
the contemplated license. Comments
and objections submitted in response to
this notice will not be made available
for public inspection, and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: September 18, 2014.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2014–22454 Filed 9–19–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Clinical and
Translational Imaging Applications.
Date: October 15, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Eileen W Bradley, DSC,
Chief, SBIB IRG, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5100, MSC 7854, Bethesda, MD
20892, (301) 435–1179, bradleye@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Vascular Biology of Diabetes and
Atherosclerosis.
Date: October 15, 2014.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Anshumali Chaudhari,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
E:\FR\FM\22SEN1.SGM
22SEN1
asabaliauskas on DSK5VPTVN1PROD with NOTICES
56592
Federal Register / Vol. 79, No. 183 / Monday, September 22, 2014 / Notices
MSC 7802, Bethesda, MD 20892, (301) 435–
1210, chaudhaa@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group,
Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 16–17, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Guangyong Ji, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3188,
MSC 7808, Bethesda, MD 20892, 301–435–
1146, jig@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group,
Gastrointestinal Mucosal Pathobiology Study
Section.
Date: October 20–21, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel & Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Jonathan K Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2190,
MSC 7850, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group,
Hepatobiliary Pathophysiology Study
Section.
Date: October 20–21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree Suites by Hilton Santa
Monica, 1707 Fourth Street, Santa Monica,
CA 90401.
Contact Person: Bonnie L Burgess-Beusse,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, 301–435–
1783, beusseb@mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group,
Community-Level Health Promotion Study
Section.
Date: October 20–21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Ping Wu, Ph.D., Scientific
Review Officer, HDM IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
Bethesda, MD 20892, 301–451–8428, wup4@
csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group, Developmental Therapeutics Study
Section.
Date: October 20–21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
VerDate Sep<11>2014
17:07 Sep 19, 2014
Jkt 232001
Agenda: To review and evaluate grant
applications.
Place: Hilton Baltimore, 401 West Pratt
Street, Baltimore, MD 21201.
Contact Person: Sharon K Gubanich, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301) 408–
9512, gubanics@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group,
Pathobiology of Kidney Disease Study
Section.
Date: October 20–21, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Atul Sahai, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2188,
MSC 7818, Bethesda, MD 20892, 301–435–
1198, sahaia@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group, Child Psychopathology and
Developmental Disabilities Study Section.
Date: October 20–21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Jane A. DoussardRoosevelt, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group,
Virology—B Study Section.
Date: October 20–21, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: John C Pugh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1206,
MSC 7808, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group, Cellular and Molecular
Biology of Neurodegeneration Study Section.
Date: October 20–21, 2014.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 5 Hotel, 711 Eastern Avenue,
Baltimore, MD 21202.
Contact Person: Laurent Taupenot, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, taupenol@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR–14–
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
089: Alzheimer’s Disease Pilot Clinical
Trials.
Date: October 20, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Mark Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–435–
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Enabling Bioanalytical and Imaging
Technologies.
Date: October 20, 2014.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications,
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Maria DeBernardi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7892, Bethesda, MD 20892, 301–435–
1355 debernardima@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 16, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–22456 Filed 9–19–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 79, Number 183 (Monday, September 22, 2014)]
[Notices]
[Pages 56591-56592]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22456]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Clinical and Translational Imaging Applications.
Date: October 15, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Eileen W Bradley, DSC, Chief, SBIB IRG, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 5100, MSC 7854, Bethesda, MD 20892, (301) 435-1179,
bradleye@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Vascular Biology of Diabetes and
Atherosclerosis.
Date: October 15, 2014.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Anshumali Chaudhari, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
[[Page 56592]]
MSC 7802, Bethesda, MD 20892, (301) 435-1210, chaudhaa@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group, Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 16-17, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Guangyong Ji, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3188, MSC 7808, Bethesda, MD 20892, 301-435-
1146, jig@csr.nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group, Gastrointestinal Mucosal Pathobiology Study
Section.
Date: October 20-21, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA
22314.
Contact Person: Jonathan K Ivins, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2190, MSC 7850, Bethesda, MD
20892, (301) 594-1245, ivinsj@csr.nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group, Hepatobiliary Pathophysiology Study
Section.
Date: October 20-21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: DoubleTree Suites by Hilton Santa Monica, 1707 Fourth
Street, Santa Monica, CA 90401.
Contact Person: Bonnie L Burgess-Beusse, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD
20892, 301-435-1783, beusseb@mail.nih.gov.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group, Community-Level Health Promotion Study
Section.
Date: October 20-21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Ping Wu, Ph.D., Scientific Review Officer, HDM
IRG, Center for Scientific Review, National Institutes of Health,
6701 Rockledge Drive, Room 3166, Bethesda, MD 20892, 301-451-8428,
wup4@csr.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group, Developmental Therapeutics Study Section.
Date: October 20-21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Baltimore, 401 West Pratt Street, Baltimore, MD
21201.
Contact Person: Sharon K Gubanich, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD
20892, (301) 408-9512, gubanics@csr.nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group, Pathobiology of Kidney Disease Study
Section.
Date: October 20-21, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Atul Sahai, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2188, MSC 7818, Bethesda, MD 20892, 301-435-
1198, sahaia@csr.nih.gov.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group, Child Psychopathology and Developmental
Disabilities Study Section.
Date: October 20-21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Jane A. Doussard-Roosevelt, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184, MSC 7848, Bethesda, MD
20892, (301) 435-4445, doussarj@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group, Virology--B Study Section.
Date: October 20-21, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: John C Pugh, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, pughjohn@csr.nih.gov.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group, Cellular and Molecular Biology
of Neurodegeneration Study Section.
Date: October 20-21, 2014.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202.
Contact Person: Laurent Taupenot, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD
20892, 301-435-1203, taupenol@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PAR-14-089: Alzheimer's Disease Pilot Clinical Trials.
Date: October 20, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Mark Lindner, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD 20892, 301-435-
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Enabling Bioanalytical and Imaging
Technologies.
Date: October 20, 2014.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications,
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Maria DeBernardi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158, MSC 7892, Bethesda, MD
20892, 301-435-1355 debernardima@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 16, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-22456 Filed 9-19-14; 8:45 am]
BILLING CODE 4140-01-P
